HONG KONG: A Trial to Accept Marketing Approval Obtained From China Food and Drug Administration - June 2018
- 2020-02-14 04:15:34
MDCO will conduct a trial to study the feasibility for Local Responsible Persons (LRP) to demonstrate that their medical devices conforms with Hong Kong requirement by using marketing approvals obtained from the China Food and Drug Administration.
More